The report outlines the company's value creation process for FY2021, highlighting the progress made towards achieving the company's 2030 Vision of becoming an ""Innovative Global Healthcare Company Contributing to the Sustainable Development of Society."" It showcases the company's commitment to ESG management and sustainability, including its efforts to reduce environmental impact, promote diversity and inclusion, and improve access to healthcare. The report also details the company's significant investment in research and development, particularly for 3ADCs, and the expansion of its global presence.
Issuing Company Daiichi Sankyo Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 10.7 MB
No. of Pages 112 pages
Reporting periodApril 1, 2021-March 31, 2022
Report EditionUnknown
Assurance Provider KPMG AZSA Sustainability Co., Ltd.
Reporting Standards GRI; SASB; UNSDGs; others
Materiality Assessmenttrue